On May 8, 2020, the FDA issued a warning letter to Plum Dragon Herbs, Inc. for selling Chinese medicine products with unsupported claims that they can treat coronavirus (COVID-19).
The company was promoting herbal medicines with statements such as "For phase 1 immunity and health, Wen Bing Defense formula, Huang Qin Extract and Wildcrafted Osha Root Extract may continue to provide beneficial support against COVID-19 before it reaches phase 2" and "CHINESE HERBS TO HELP MAINTAIN IMMUNE SYSTEM HEALTH DURING CORONA VIRUS, COVID-19 AND CYTOKINE STORM."
The FDA has previously stated: "There currently are no vaccines, pills, potions, lotions, lozenges or other prescription or over-the-counter products available to treat or cure coronavirus disease 2019 (COVID-19)."
The agency instructed the companies to send an email to COVID-19-Task-Force-CDER@fda.hhs.gov within 48 hours of receipt of the warning, describing the specific steps they have taken to correct these violations.
For other Recalls and Warnings click HERE.For information about reporting serious reactions and problems with medical products to the U.S. Food and Drug Administration through its MedWatch reporting program, please go to http://www.fda.gov/medwatch/how.htm.
Sign up for FREE Newsletter
BECOME A MEMBER
Instant Access to Reviews for OVER 1,000 Products!